Ticker League

Price Target for Agilent Technologies (A)

Interactive scenarios for Agilent Technologies (A) at about $129.55. Default base case lands near $437.17 in 5 years from 23% growth and a 32× exit P/E — about a 27.5% CAGR.

Near 5-year median
Analysis

Stock price

$129.55

TTM EPS

$4.98

P/E (TTM)

31.79

Net debt

$1.6B

Beta

1.26

Valuation context

How today's valuation compares to its own 5-year history.

P/E vs 5Y median

Where today's P/E sits versus its trailing five-year median.

+0.0%
Fair value
DiscountFair valuePremiumStretched
−50%at median+50%

A's P/E sits within ±10% of its trailing 5-year median — broadly in line with its own history.

Breakdown5Y low · median · 5Y highToday
P/E
24.531.839.5
31.8
P/S
4.46.07.6
6.0
EV/EBITDA
18.522.627.8
23.4
EPS 5Y
5Y CAGR+14.7%
PEG2.17(demanding vs growth)

Scenario calculator

Enter EPS growth and exit P/E per scenario. The chart starts at the current share price (Now) and transitions the P/E from today's trailing multiple toward your Exit P/E over the horizon. Same live price and TTM EPS as the rest of the page.

Whole number from 1 to 10 years.
bear
Percent per year from negative thirty to fifty. Use a period or comma as the decimal separator.
Exit price-to-earnings multiple, whole number from 5 to 80.
base
Percent per year from negative thirty to fifty. Use a period or comma as the decimal separator.
Exit price-to-earnings multiple, whole number from 5 to 80.
bull
Percent per year from negative thirty to fifty. Use a period or comma as the decimal separator.
Exit price-to-earnings multiple, whole number from 5 to 80.

Base case: with about 23% growth per year and a 32× exit multiple over 5 years, the model lands A near $437.17 — an implied about a 27.5% CAGR.

Your base case implies a $193.97 12-month target. Save it to join the community consensus.

Implied price path (by year)

Paths start at $129.55 (Now); the P/E transitions from today's trailing multiple toward Exit P/E by the horizon year.

At horizon (2031)

  • Bear$377.16
  • Base$437.17
  • Bull$481.76

Sensitivity (base case)

Sensitivity grid — sweeps EPS growth and exit P/E around your base inputs. Simple mode only; bear, bull, and Advanced (revenue) paths are not included.

Implied share price at the horizon for each combination: EPS growth in the rows, exit P/E in the columns; other settings stay fixed.

Row axis: EPS growth. Column axis: exit P/E.Exit P/E →↓ EPS growth22×27×32×37×42×
13%$196$241$286$331$375
18%$243$299$355$411$467
23%$300$368$437$506$575
28%$366$450$534$618$702
33%$444$545$647$749$851
LegendGreen: >10% above today's priceAmber: within ±10%Red: >10% below today's price

Shade depth: darker fill within the same color band means a higher implied price in that cell (across the grid).

Annual diluted EPS

GAAP diluted EPS by fiscal year — use as context for growth assumptions above, not a forecast. Across 14 fiscal years, diluted EPS went from about $3.27 in 2012 to about $4.57 in 2025.

Scale: 0.97 to 4.57 EPS; horizontal line at 0. Fiscal years with no row in the database are omitted.

Diluted EPS year-over-year change

Percent change vs the previous fiscal year. If a fiscal year is missing, the comparison is to the prior available year. Year-over-year EPS change in this window ranged from a high of +247.4% to a low of -53.8%.

Your EPS growth vs next-year analyst consensus

Same basis for every column: one-step implied EPS growth (next-year average estimate vs TTM). Consensus uses 11 EPS estimates. Δ (pts) is your growth minus consensus in percentage points, not "percent of consensus."

Agilent Technologies (A) Key Financials

Charts, filings, and peer comparison for every metric

This analysis is for informational purposes only and is not financial advice. Scenario prices and DCF-style figures depend on your assumptions and data from public filings and estimates. They are not forecasts of future returns.

Community price target

Where A forecasters and Wall Street see the stock 12 months out. The community figure is the median saved base-case target across members, shown once at least 5 members have saved one.

Community 12-month—Appears at 5+ saved targets
Wall Street$155.43analyst consensus target
Current price$129.55latest market price

Relative valuation

How A trades versus its Healthcare peers and its own history. Lower multiples are cheaper; the band marks where each multiple sits between its 5-year low (left) and high (right).

In line
  • P/E (TTM)23.1×
    Cheap
  • EV/EBITDA18.4×
    Expensive
  • P/S (TTM)4.5×
    In line

Peers in the Healthcare sector

Compare A against its Healthcare peers on the three core multiples. Lower is cheaper; tap a column to rank the peer set. Open any peer's price target page for its full scenario breakdown. Filtered to active common stock, excluding ETFs and funds.

About the A price target calculator

The A price target calculator projects a future share price by compounding trailing twelve-month earnings per share at an assumed growth rate and applying an exit P/E multiple at the end of the horizon. The stock currently trades at about $129.55, a P/E of roughly 31.8× on TTM EPS of $4.98.

11 analysts cover A for the next fiscal year, with EPS estimates ranging from $5.97 to $6.13 and a consensus average of $6.06. Versus the latest TTM EPS of about $4.98, that consensus implies roughly 21.7% growth next year. That sits faster than the trailing 5-year EPS history of 14.7% growth per year — one useful sanity check on whether consensus is anchored to history or expecting a regime change.

Frequently asked questions

Explore more

Deep-dives across the income statement, cash flow, capital return, and valuation

Overview